CIPLA LIMITED FDA Approval ANDA 090155

ANDA 090155

CIPLA LIMITED

FDA Drug Application

Application #090155

Documents

Letter2009-08-06

Application Sponsors

ANDA 090155CIPLA LIMITED

Marketing Status

None (Tentative Approval)001

Application Products

001CAPSULE; ORAL200MG0EFAVIRENZEFAVIRENZ

FDA Submissions

ORIG1TA2009-08-03

Submissions Property Types

ORIG1Null42

CDER Filings

CIPLA LIMITED
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90155
            [companyName] => CIPLA LIMITED
            [docInserts] => ["",""]
            [products] => [{"drugName":"EFAVIRENZ","activeIngredients":"EFAVIRENZ","strength":"200MG","dosageForm":"CAPSULE; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"EFAVIRENZ","submission":"EFAVIRENZ","actionType":"200MG","submissionClassification":"CAPSULE; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.